2 min read

Insider Trading Report: January 22, 2026 — No Purchases or Sales Across 5 Companies

No purchases or sales were filed on January 22, 2026, across 15 transactions in 5 companies totaling $1.6M. Highlights include a $1.4M award to an MBX director and tax payments at BHRB and SR. Secondary activity dominates without primary buy/sell signals. (214 characters)

Overview

On January 22, 2026, insider trading filings revealed 15 transactions across 5 unique tickers: BHRB, CCBG, MBX, SR, and VAC, with a total value of $1.6M. Notably, there were 0 purchases and 0 sales—the most important signals of insider confidence or potential concerns—leaving only secondary transactions like awards, tax payments, and option exercises.

While the absence of buys or sells tempers any strong directional signals, the activity provides context on routine insider moves. MBX led with $1.4M in value from 2 transactions, followed by BHRB at $148K across 6 filings, amid a combined market cap footprint exceeding $10B for these firms.

Primary Insider Transactions (Purchases & Sales)

Purchases and sales are the most meaningful insider signals, as buys often indicate confidence in future growth while sales may reflect diversification, tax needs, or other factors. Today, there were no such transactions filed.

No purchases or sales filed today.

Other Transactions (Awards, Options, etc.)

Secondary transactions, such as awards, option exercises, and tax payments, appeared in today's filings but are generally less indicative of directional sentiment compared to outright purchases or sales. MBX saw the largest with a $1.4M director award, while BHRB and SR reported tax payments totaling around $262K combined.

These moves, including 7 awards (primarily $0 value except MBX), 4 tax payments, 3 option exercises, and 1 other, highlight routine compensation-related activity rather than strategic buying or selling.

Ticker Insider Type Value Filing Date
MBX Stelzer Laurie Award $1.4M 2026-01-22
SR Doyle Scott Edward Tax Payment $114K 2026-01-22
BHRB BOYLE DAVID P Tax Payment $112K 2026-01-22
BHRB Halyama Roy Eugene Tax Payment $29K 2026-01-22
BHRB Rowan Shannon Barrow Tax Payment $7K 2026-01-22

Recent News

No primary transactions (purchases or sales) today, so no associated news highlights. For context on active tickers:

BHRB (Burke & Herbert Financial Services)

  • Burke & Herbert Financial Services (OTCMKTS:BHRB) Shares Down 2.1% – Here’s Why (defenseworld.net)

CCBG (Capital City Bank Group)

  • Capital City Bank Group, Inc. to Announce Quarterly Earnings Results on Tuesday, January 27, 2026 (globenewswire.com)
  • Capital City Bank Group (NASDAQ:CCBG) Share Price Passes Above Two Hundred Day Moving Average – What’s Next? (defenseworld.net)

MBX (MBX Biosciences)

  • MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair (globenewswire.com)
  • MBX Biosciences, Inc. (MBX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript (seekingalpha.com)
  • MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morga (globenewswire.com)

SR
No recent headlines available.

VAC
No recent headlines available.

What This Means

Insider purchases are strong bullish signals, suggesting executives see undervaluation or growth ahead, while sales warrant scrutiny for size relative to holdings and timing. With zero primary transactions today, there's no clear directional bias from insiders—activity centered on non-discretionary items like awards and taxes, which often tie to compensation plans rather than market views.

Use this data as one piece of a broader research puzzle, alongside earnings, valuations, and technicals. Insiders transact for diverse reasons, including liquidity needs or gifting, so context matters. Track clusters over time for patterns.

This report draws from publicly available SEC filings. It's educational, not a recommendation.


Independent, data-driven market research.
No hype. No promotions. Zero bias. Just experimental insights from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

If this analysis helped you, feel free to like, share, or subscribe — it helps the channel grow steadily. 🙏